Telogen Effluvium and Anesthesia Considerations: A Case Report

Telogen effluvium is a form of non-scarring hair loss characterized by premature shedding of hair. Pathophysiologically, telogen effluvium occurs when a significant number of hair follicles prematurely enter the telogen phase, resulting in excessive shedding. The exact mechanism is unclear, but it is believed to involve alterations in the hair follicle's growth cycle, possibly mediated by illness, infection, major surgery, low protein intake, or hormonal changes. Some medications can also be linked to this disease, such as beta blockers, carbamazepine, and vitamin A. When affected hairs are in the resting phase, noticeable hair shedding occurs. Our patient was a 61-year-old female with a history of telogen effluvium, and exacerbations occurred after surgery. She presented for a reduction and internal fixation of her left tibia and left lateral meniscus repair after a fall. She was very concerned about the possibility of undergoing surgery, as recent exacerbations had caused significant hair loss over several months. There are no guidelines on anesthesia considerations for patients with this rare disorder. This case report hopes to shed light on techniques to reduce exacerbations in these patients.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-07-20
DOI
https://doi.org/10.7759/cureus.88366
Citations
1
Primary Topic
Hair Growth and Disorders
Type
article
Field-Weighted Citation Impact
1.84
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Telogen Effluvium and Anesthesia Considerations: A Case Report

Hanen Fernandez, Matt Brown, Matthias Franzen, Elizabeth Johnson-Gray et al.
1 citations
Cureus
Hair Growth and Disorders
1.84
article

Telogen Effluvium and Anesthesia Considerations: A Case Report

Hanen Fernandez, Matt Brown, Matthias Franzen, Elizabeth Johnson-Gray, Samantha A Currier
article en
1 citations

Abstract

Telogen effluvium is a form of non-scarring hair loss characterized by premature shedding of hair. Pathophysiologically, telogen effluvium occurs when a significant number of hair follicles prematurely enter the telogen phase, resulting in excessive shedding. The exact mechanism is unclear, but it is believed to involve alterations in the hair follicle's growth cycle, possibly mediated by illness, infection, major surgery, low protein intake, or hormonal changes. Some medications can also be linked to this disease, such as beta blockers, carbamazepine, and vitamin A. When affected hairs are in the resting phase, noticeable hair shedding occurs. Our patient was a 61-year-old female with a history of telogen effluvium, and exacerbations occurred after surgery. She presented for a reduction and internal fixation of her left tibia and left lateral meniscus repair after a fall. She was very concerned about the possibility of undergoing surgery, as recent exacerbations had caused significant hair loss over several months. There are no guidelines on anesthesia considerations for patients with this rare disorder. This case report hopes to shed light on techniques to reduce exacerbations in these patients.

CureusVol. 17(7)
OhioHealth (US), Kansas City University (US)
Climate action
Openalex Percentile: Top 15%
Hair Growth and Disorders
1.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.